In breast cancer, CD146 induces the epithelial-to-mesenchymal transition (EMT), a crucial process in cancer metastasis [11], gaining stem cell-like properties [12] and generating cells known as Cancer Stem Cells (CSC). Here, MCAM is linked to breast cancer.